Powell Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$889K Hold
7,040
0.28% 53
2026
Q1
$981K Hold
7,040
0.34% 43
2025
Q4
$864K Hold
7,040
0.3% 49
2025
Q3
$781K Hold
7,040
0.27% 54
2025
Q2
$781K Buy
+7,040
New +$749K 0.29% 49
2025
Q1
Sell
-7,040
Closed -$650K 152
2024
Q4
$650K Hold
7,040
0.3% 50
2024
Q3
$590K Sell
7,040
-57
-0.8% -$4.35K 0.28% 55
2024
Q2
$487K Hold
7,097
0.25% 62
2024
Q1
$520K Sell
7,097
-21
-0.3% -$1.61K 0.27% 58
2023
Q4
$577K Hold
7,118
0.32% 50
2023
Q3
$533K Buy
7,118
+1
+0% +$77 0.32% 53
2023
Q2
$549K Hold
7,117
0.32% 54
2023
Q1
$591K Buy
7,117
+20
+0.3% +$1.66K 0.33% 53
2022
Q4
$609K Hold
7,097
0.35% 50
2022
Q3
$438K Buy
7,097
+2,646
+59% +$167K 0.29% 60
2022
Q2
$275K Buy
+4,451
New +$276K 0.17% 87

Other funds holding GILD

Powell Investment Advisors's GILD Position: Q2 2026 in Review

Powell Investment Advisors held its Gilead Sciences (GILD) position steady in Q2 2026 at 7,040 shares worth $889K. The position accounts for 0.28% of the portfolio, ranked #53.

Powell Investment Advisors first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. The position peaked at $981K in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Powell Investment Advisors held 7,040 shares of Gilead Sciences worth $889K as of Q2 2026.
  • Powell Investment Advisors left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.28% of Powell Investment Advisors's portfolio in Q2 2026, its #53 holding.
  • Powell Investment Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • Powell Investment Advisors's Gilead Sciences position peaked at $981K in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Powell Investment Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.